Kansas has reached a settlement with a major pharmaceutical company and three opioid distributors as part of the state’s ongoing efforts to bring accountability to those that fueled the opioid addiction crisis and provide funds to support addiction services. Kansas Attorney General Derek Schmidt gives the details of the settlement.

In addition to financial terms, the distributors have also agreed to help prevent a similar prescription-drug crisis from happening again. Johnson & Johnson will stop selling opioids, will not fund or provide grants to third parties for promoting opioids, and will not lobby on activities related to opioids. Schmidt said an estimate of how much money Kansas will receive will be released at a later date.